Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-3.31 Mil
% of Total Estimate Gain
-40.78%

Memorial Sloan Kettering Cancer Center's Illumina Inc Holding Summary

As of 2023-09-30, Memorial Sloan Kettering Cancer Center held - shares of Illumina Inc(ILMN), totaling N/A. This investment constitutes 0% of their stock portfolio, and Memorial Sloan Kettering Cancer Center now holds 0% of the outstanding Illumina Inc(ILMN) stock.

The initial trade took place in 2021Q3. And since then Memorial Sloan Kettering Cancer Center has made 1 purchases of ILMN, at an average price of $472.70, for a total of 17,196.00 shares. In addition, there have been 3 sales at an average price of $279.93 for 17,196.00 shares. Based on historical transaction data and ILMN's current price of $90.61, Memorial Sloan Kettering Cancer Center's estimated gain on his ILMN holdings is $-3.31 Mil, reflecting a -40.78% gain to date.

Memorial Sloan Kettering Cancer Center ILMN ($90.61) Holding Chart

Memorial Sloan Kettering Cancer Center ILMN ($90.61) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1